Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.49 USD | +1.36% | -10.88% | +3.06% |
Mar. 13 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
Mar. 13 | Spero Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.06% | 79.19M | |
-3.31% | 102B | |
+3.33% | 96.09B | |
-1.02% | 22.05B | |
-18.34% | 20.81B | |
-6.87% | 19.06B | |
-40.70% | 16.05B | |
-26.01% | 14.01B | |
+1.76% | 13.38B | |
+22.92% | 11.01B |
- Stock Market
- Equities
- SPRO Stock
- News Spero Therapeutics, Inc.
- Earnings Flash (SPRO) SPERO THERAPEUTICS Posts Q3 Revenue $2M